Mary Ann Banerji, MD
- 7Articles
- 10.4KReads1
- 2004Active
- 10Collaborators
1 Read counts for articles published before 2020 may include some non-human traffic.
About
Mary Ann Banerji, MD, has published extensively on metabolic disorders and weight-related issues in psychiatric treatment, focusing on antipsychotic drugs and their association with insulin resistance, hyperglycemia, and diabetes mellitus. Her work addresses the epidemiology of cardiovascular disease and metabolic risk factors, as well as monitoring and managing metabolic side effects in patients with schizophrenia. Banerji’s research includes treatment recommendations for psychiatrists concerning atypical antipsychotic-induced weight gain and related metabolic abnormalities.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
